Serina Therapeutics SER
NYSE SER
$1.51 +0.08 (+5.59%)
As of: Nov 11, 2026 · 3:59 PM EST

Serina Therapeutics (SER) Return on Equity [ROE] (2018 - 2026)

Updated

Serina Therapeutics' Return on Equity [ROE] came in at -222.00% for Q2 2026, up 567.58 percentage points from -789.58% a year earlier.

Analysis

Serina Therapeutics (SER) Return on Equity [ROE] (2018 - 2026) Analysis & Trends

For FY2025, Serina Therapeutics' Return on Equity [ROE] was -8159.24%.

  • The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Serina Therapeutics 23.59 Mn -35.63 Mn - -116.54%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -116.54%
Mar 31, 2026 -242.07%
Dec 31, 2025 -2,230.41%
Sep 30, 2025 -1,094.01%
Jun 30, 2025 -789.58%
Mar 31, 2025 -98.11%
Mar 31, 2020 -1,105.71%
Dec 31, 2019 -327.62%
Sep 30, 2019 -209.18%
Jun 30, 2019 -135.65%
Mar 31, 2019 -116.34%
Dec 31, 2018 -81.52%
API Access

Serina Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SER&period=max&api_key=YOUR_API_KEY